While popular drugs like Ozempic and Wegovy are only available as injections, drugmaker Novo Nordisk is working on a more ...

Novo expects to continue to grow its reach in 2025, though perhaps not at the magnitude witnessed in 2024. For the full year to come, Novo Nordisk is eyeing sales growth at constant currencies between ...

In fact, Novo Nordisk recently reported positive results for one of its anti-obesity candidates that puts its current ...

Eli Lilly and Company (NYSE:LLY), a leading pharmaceutical giant with a market capitalization of $724 billion, has been ...

Tori Allen says she's thrilled to have lost 80 pounds since she went on Wegovy, one of the GLP-1 drugs that more and more people are using to treat diabetes or lose weight.

Parting with society’s outward measures of ambition and success let me be bold enough to allow myself to learn and grow in new areas, like writing, community-building and research. For years ...

One of Novo Nordisk's next-generation obesity shots to follow up on the success of Wegovy helped patients lose 22% of their ...

You don't have to be a prodigy to flourish. The following successful entrepreneurs did not accomplish their defining success until after the age of 30. (And don't worry if you don't feel like you're a ...

A large study published in Nature Medicine reviewed the effects of GLP-1 drugs like Ozempic and Mounjaro on 175 different ...

Ozempic, Wegovy, Mounjaro, and Zepbound are all classified ... I say this because so many of my patients have found success with these drugs but now tell me that they are ‘terrified to get ...

It arrives at a time when anecdotal reports and small studies attesting to new effects of drugs sold under brand names such as Mounjaro, Ozempic, Wegovy and Zepbound emerge regularly.

Having made waves the world over, revolutionary anti-obesity drugs Wegovy and Ozempic (manufactured by Danish drugmaker Novo Nordisk), and Eli Lilly’s tirzepatide are set to enter the Indian ...